CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Planned sale Chief Legal Officer sold 4,005 shares at $35.54 ($142,338)
- 4 Planned sale Chief Financial Officer sold 2,275 shares at $35.54 ($80,854)
- 4 Planned sale Chief Commercial Officer sold 1,681 shares at $35.54 ($59,743)
- 4 Planned sale Chief Executive Officer sold 12,947 shares at $35.54 ($460,136)
- 4 Planned sale Chief Medical Officer sold 4,005 shares at $35.54 ($142,338)
- 4 Planned sale Principal Accounting Officer sold 1,655 shares at $35.54 ($58,819)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Planned sale Principal Accounting Officer sold 2,272 shares at $34.39 ($78,134)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
Page 9 of 66 · 1,304 filings